Biotech Startup. Watch Closely
This could be the window of opportunity you've been seeking for.
Get our report here.

ALNA Insider Trading (Allena Pharmaceuticals)

Insider Ownership Percentage: 22.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $233,465.76

Allena Pharmaceuticals Insider Trading History Chart

Allena Pharmaceuticals Share Price & Price History

$1.81
▲ +0.17 (10.37%)
As of 02/24/2021 01:00 AM ET
Days: 30 | 90 | 365
Are you looking for the next great pet stock play?
Don't miss this opportunity as FRPT is already trading over 100 dollars per share!
Read more here about the next great pet stock!

Allena Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2020Edward WholihanCFOSell68,550$1.36$93,228.00121,272  
12/17/2020Louis Md BrennerCEOSell103,116$1.36$140,237.76144,816  
See Full Table

SEC Filings (Institutional Ownership Changes) for Allena Pharmaceuticals (NASDAQ:ALNA)

28.03% of Allena Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Allena Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/17/2021Worth Venture Partners LLC510,200$0.65M0.5%+24.8%1.332%
2/10/2021Renaissance Technologies LLC247,011$0.32M0.0%N/A0.645%
2/5/2021BlackRock Inc.164,056$0.21M0.0%+21.3%0.428%
1/25/2021Golden Green Inc.39,000$50K0.0%N/A0.102%
11/16/2020Worth Venture Partners LLC408,840$0.61M0.5%+60.3%1.068%
11/13/2020Morgan Stanley1,051,627$1.56M0.0%-2.7%2.746%
10/20/2020Wedbush Securities Inc.24,150$36K0.0%-50.9%0.063%
8/17/2020Jacobs Levy Equity Management Inc.126,672$0.20M0.0%-28.3%0.332%
8/14/2020Worth Venture Partners LLC255,000$0.40M0.2%+148.1%1.031%
8/14/2020Sabby Management LLC1,531,446$2.42M0.5%N/A6.190%
8/14/2020Advisor Group Holdings Inc.20,000$32K0.0%+81.8%0.081%
8/12/2020Algert Global LLC17,340$27K0.0%-51.3%0.070%
8/12/2020Goldman Sachs Group Inc.28,112$44K0.0%N/A0.114%
7/16/2020Wedbush Securities Inc.49,150$78K0.0%+103.5%0.199%
5/15/2020Morgan Stanley1,253,847$1.21M0.0%+56.1%5.068%
5/14/2020Sphera Funds Management LTD.667,800$0.64M0.1%-27.2%2.699%
5/1/2020BlackRock Inc.120,556$0.12M0.0%-6.0%0.487%
2/20/2020Geode Capital Management LLC105,854$0.29M0.0%+103.0%0.451%
2/18/2020Algert Global LLC36,840$0.10M0.0%N/A0.157%
2/14/2020Goldman Sachs Group Inc.33,784$92K0.0%-59.3%0.144%
2/13/2020Banco Bilbao Vizcaya Argentaria S.A.38,113$0.10M0.0%N/A0.162%
2/13/2020Renaissance Technologies LLC241,700$0.66M0.0%+91.2%1.030%
1/16/2020Wedbush Securities Inc.50,150$0.14M0.0%+95.5%0.214%
11/27/2019Millennium Management LLC484,625$1.91M0.0%+48.8%2.065%
10/17/2019Wedbush Securities Inc.25,650$0.10M0.0%+66.6%0.109%
8/16/2019Susquehanna International Group LLP33,565$0.14M0.0%N/A0.143%
8/15/2019Jane Street Group LLC28,570$0.12M0.0%N/A0.122%
8/14/2019Morgan Stanley1,744,095$7.10M0.0%-2.3%7.432%
8/14/2019Paloma Partners Management Co52,100$0.21M0.0%N/A0.222%
8/14/2019Vanguard Group Inc.468,190$1.91M0.0%-10.2%1.995%
8/13/2019Jacobs Levy Equity Management Inc.41,587$0.17M0.0%+17.0%0.177%
8/13/2019BlackRock Inc.115,656$0.47M0.0%-81.0%0.493%
8/13/2019Northern Trust Corp112,945$0.46M0.0%-6.5%0.481%
8/12/2019Bank of New York Mellon Corp23,719$96K0.0%-24.4%0.101%
8/7/2019JPMorgan Chase & Co.46,901$0.20M0.0%-78.6%0.225%
8/6/2019Wells Fargo & Company MN11,751$48K0.0%-44.9%0.056%
8/1/2019Wedbush Securities Inc.15,400$63K0.0%N/A0.074%
6/20/2019Sphera Funds Management LTD.431,193$3.03M0.3%+24.9%2.071%
4/1/2019Deutsche Bank AG28,023$0.15M0.0%+8.2%0.135%
2/14/2019Squarepoint Ops LLC43,500$0.24M0.0%+3.8%0.210%
2/14/2019Perceptive Advisors LLC132,300$0.70M0.0%-47.1%0.637%
2/14/2019Sphera Funds Management LTD.345,199$1.88M0.2%+16.9%1.663%
2/13/2019Geode Capital Management LLC72,314$0.39M0.0%+8.1%0.348%
2/11/2019Bank of New York Mellon Corp29,521$0.16M0.0%-7.3%0.142%
2/8/2019BlackRock Inc.581,971$3.17M0.0%+0.8%2.803%
2/8/2019New York State Common Retirement Fund12,100$66K0.0%-16.0%0.058%
1/31/2019Rhumbline Advisers14,349$78K0.0%N/A0.069%
1/31/2019Fosun International Ltd29,877$0.15M0.0%N/A0.144%
12/13/2018Vanguard Group Inc349,819$3.76M0.0%+2.2%1.685%
11/23/2018Vanguard Group Inc.349,819$3.76M0.0%+2.2%1.685%
11/20/2018Morgan Stanley1,856,640$19.94M0.0%+126.0%8.943%
11/14/2018Sphera Funds Management LTD.295,199$3.17M0.4%+10.4%1.422%
11/13/2018Partner Fund Management L.P.1,768,568$18.99M0.3%+1.7%8.519%
11/13/2018Citadel Advisors LLC10,776$0.12M0.0%N/A0.052%
11/9/2018FMR LLC1,489,783$16M0.0%-20.2%7.180%
11/9/2018BlackRock Inc.577,443$6.20M0.0%+1.7%2.783%
10/25/2018Alps Advisors Inc.36,722$0.39M0.0%+22.3%0.177%
9/18/2018Northern Trust Corp113,981$1.49M0.0%+94.0%0.549%
8/15/2018Millennium Management LLC219,351$2.86M0.0%+138.2%1.057%
8/15/2018Partner Fund Management L.P.1,739,805$22.67M0.4%+18.8%8.385%
8/15/2018Partner Investment Management L.P.298,005$3.88M3.1%-48.2%1.436%
8/10/2018FMR LLC1,865,777$24.31M0.0%-15.6%8.992%
8/9/2018BlackRock Inc.567,707$7.40M0.0%+145.1%2.743%
8/8/2018Spark Investment Management LLC16,000$0.21M0.0%N/A0.077%
8/8/2018Schwab Charles Investment Management Inc.21,600$0.28M0.0%N/A0.104%
8/6/2018Bank of New York Mellon Corp31,137$0.41M0.0%+205.8%0.150%
8/6/2018Rhumbline Advisers10,222$0.13M0.0%N/A0.049%
8/2/2018Alps Advisors Inc.30,036$0.39M0.0%N/A0.145%
7/24/2018Acadian Asset Management LLC18,539$0.24M0.0%N/A0.090%
5/16/2018Millennium Management LLC92,079$1.02M0.0%+311.9%0.445%
5/11/2018Citadel Advisors LLC11,265$0.12M0.0%N/A0.054%
5/10/2018JPMorgan Chase & Co.195,771$2.16M0.0%-45.3%0.946%
5/10/2018Sphera Funds Management LTD.410,199$4.52M0.7%+26.2%1.982%
5/9/2018BlackRock Inc.231,654$2.55M0.0%+2.2%1.119%
5/2/2018Wells Fargo & Company MN9,336$0.10M0.0%+246.4%0.045%
2/15/2018Millennium Management LLC22,356$0.23M0.0%N/A0.108%
2/14/2018Perceptive Advisors LLC250,000$2.52M0.1%N/A1.209%
2/14/2018Goldman Sachs Group Inc.49,643$0.50M0.0%N/A0.240%
2/14/2018Deutsche Bank AG11,846$0.12M0.0%N/A0.057%
2/14/2018Needham Investment Management LLC18,288$0.26M0.1%N/A0.088%
2/13/2018Frazier Management LLC3,330,373$33.50M5.4%N/A16.112%
2/12/2018Sphera Funds Management LTD.325,000$3.27M0.4%N/A1.572%
2/9/2018BlackRock Inc.226,775$2.28M0.0%N/A1.097%
2/9/2018Bank of New York Mellon Corp10,182$0.10M0.0%N/A0.049%
1/31/2018Dean Capital Investments Management LLC11,568$0.12M0.0%N/A0.056%
Data available starting January 2016

See Full Table
Allena Pharmaceuticals logo
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic that is in phase 3 clinical program for the treatment of hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and moderate to severe chronic kidney diseases. Allena Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Newton, Massachusetts.
Read More

Today's Range

Now: $1.81
$1.71
$1.84

50 Day Range

MA: $1.75
$1.32
$2.17

52 Week Range

Now: $1.81
$0.53
$3.39

Volume

932,442 shs

Average Volume

3,285,956 shs

Market Capitalization

$69.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.39

Who are the company insiders with the largest holdings of Allena Pharmaceuticals?

Allena Pharmaceuticals' top insider shareholders include:
  1. Louis Md Brenner (CEO)
  2. Edward Wholihan (CFO)

Who are the major institutional investors of Allena Pharmaceuticals?

Allena Pharmaceuticals' top institutional shareholders include:
  1. Worth Venture Partners LLC — 1.33%
  2. Renaissance Technologies LLC — 0.65%
  3. BlackRock Inc. — 0.43%
  4. Golden Green Inc. — 0.10%

Which institutional investors are buying Allena Pharmaceuticals stock?

Within the last quarter, ALNA stock was acquired by institutional investors including:
  1. Renaissance Technologies LLC
  2. Worth Venture Partners LLC
  3. Golden Green Inc.
  4. BlackRock Inc.
Hire a Pro: Compare Financial Advisors in Your Area
Finding the right financial advisor to fit your needs doesn't have to be hard. SmartAsset's free quiz matches you with fiduciary financial advisors in your area in 5 minutes. Each advisor is legally bound to act in your best interest.
If you're ready to acheive your financial goals, get started now.
pixel